When is the next round of Covid vaccine boosters?
Pressure growing on ministers to offer jabs to all adults over autumn and winter
Nearly three million adults in England who have not been vaccinated against Covid are being urged to come forward as a fresh wave of the virus sweeps across the country.
Experts say the number of unjabbed adults includes elderly and vulnerable people “who could get extremely sick” if they were infected with the new variants of the coronavirus, the BBC reported.
Pressure is building on the government to offer booster vaccines to many other groups too, as latest figures from the Office for National Statistics show that the number of Covid deaths in the UK has passed 200,000.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A fifth jab
Following the nationwide rollout of the first two Covid jabs, a booster was offered last year to everyone aged 16 and over, and to some children aged 12 to 15. Another booster was rolled out this spring for people aged 75 and over, residents in care homes, and people aged 12 and over with weakened immune systems.
And in June Professor Adam Finn, a member of the government’s Joint Committee on Vaccination and Immunisation (JCVI), “suggested a fifth jab will need to be rolled out for the most vulnerable as immunity to the virus gained by previous booster campaigns wanes”, reported The Independent. Finn advised that the rollout should begin in September, when the NHS usually also begins a major push to deliver flu vaccines.
But who will be offered Covid jabs during the next round of boosters remains unclear.
Official interim advice from the JCVI published in May recommended that a booster should be offered in the autumn to all people aged 65 and over; residents and staff in care homes for older adults; front-line health and social care workers and adults aged 16 to 64 in clinical risk groups.
But with Covid “still rampant” and the threat of another “troublesome variant” emerging before winter, the committee’s advice was “provisional”, said The Guardian’s science editor Ian Sample.
A broader campaign?
The Financial Times has speculated that the government is preparing to roll out Covid-19 booster jabs to all adults aged over 50, in a “broader autumn campaign” than its vaccine advisers had previously suggested. Updated advice from the JCVI is expected soon.
Meanwhile, several immunologists and public health experts have advised the government to go even further, offering jabs to all adults over the autumn and winter.
Devi Sridhar, professor of public health at Edinburgh University, told the FT that the booster programme should be broadened to reduce the economic, educational and social costs of the disease – and long Covid – in younger people.
“The problem is that JCVI focuses on avoiding hospitalisation and death from severe Covid,” she said.
However, before he left the post, the former health secretary, Sajid Javid, said that it was “highly unlikely” the programme would be extended to all adults.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Today's political cartoons - December 21, 2024
Cartoons Saturday's cartoons - losing it, pedal to the metal, and more
By The Week US Published
-
Three fun, festive activities to make the magic happen this Christmas Day
Inspire your children to help set the table, stage a pantomime and write thank-you letters this Christmas!
By The Week Junior Published
-
The best books of 2024 to give this Christmas
The Week Recommends From Percival Everett to Rachel Clarke these are the critics' favourite books from 2024
By The Week UK Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Last updated
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published